Live Breaking News & Updates on கல்லீரல் மாற்று அலகு

Stay updated with breaking news from கல்லீரல் மாற்று அலகு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vadapalani's SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu


Vadapalani s SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu
ANI |
Updated: Apr 01, 2021 17:17 IST
Chennai (Tamil Nadu) [India], April 1 (ANI/NewsVoir): SIMS Hospitals (SRM Institutes for Medical Science) Vadapalani, one of the leading multi-speciality hospitals in Chennai, performed successful Liver transplant surgery under an operating microscope, marking a significant development in the field of Liver transplant surgery in the State of Tamil Nadu.
This skill-intensive Microsurgical Liver transplant evidently reduces the post-surgical complications to a larger extent and ensures better outcomes for patients.
Sharing his thoughts on the successful transplant and the benefits of Microsurgical Liver Transplant Surgery, Dr S. Vivekanandan, Lead Surgeon, Liver Transplant, SIMS, said, Conventionally, liver transplants are done using magnifying glasses (also known as Surgical L ....

Tamil Nadu , State Of Tamil Nadu , Medical Science , Microsurgical Liver , Microsurgical Liver Transplant Surgery , Lead Surgeon , Liver Transplant , Surgical Loupes , Microsurgical Liver Transplant , Liver Transplant Unit , Living Donors , Cadaveric Liver , Liver Surgeons , Bi Plane Cath , Dr Vivekanandan , Sims Hospitals , தமிழ் நாடு , நிலை ஆஃப் தமிழ் நாடு , மருத்துவ அறிவியல் , மைக்ரோ சர்ஜிக்கல் கல்லீரல் , மைக்ரோ சர்ஜிக்கல் கல்லீரல் மாற்று அறுவை சிகிச்சை , வழி நடத்து அறுவை சிகிச்சை நிபுணர் , கல்லீரல் மாற்று , மைக்ரோ சர்ஜிக்கல் கல்லீரல் மாற்று , கல்லீரல் மாற்று அலகு , வாழும் நன்கொடையாளர்கள் ,

Vadapalani's SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu

Coronavirus | Covaxin gets central drugs authority panel approval for restricted use


Coronavirus | Covaxin gets central drugs authority panel approval for restricted use
Updated:
Updated:
Bharat Biotech’s vaccine candidate approved for use in clinical trial mode.
Share Article
AAA
A health worker administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, during phase- 3 trials for the vaccine candidate at the People’s Medical College in Bhopal on December 7, 2020.   | Photo Credit:
PTI
Bharat Biotech’s vaccine candidate approved for use in clinical trial mode.
India’s first indigenously developed COVID-19 vaccine, Covaxin, has been recommended for “restricted use in emergency situation, subject to multiple regulatory conditionalties” by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), here on Saturday. The Drugs Controller General (DCGI) will take a final call on approving rollout of the vaccine in the country. ....

United Kingdom , Rahul Pandit , Arvind Soin , Indian Council Of Medical Research , Health Ministry , Central Drugs Standard Control Organisation , Icmr National Institute Of Virology , Pune Serum Institute Of India , Expert Committee , Serum Institute Of India , Oxford University , Subject Expert Committee , Drugs Controller General , Serum Institute , Bharat Biotech , Liver Transplant Unit , Medanta Hospital Arvind Soin , Indian Council , Medical Research , United Kingdom Variant , United Kingdom Returnees , ஒன்றுபட்டது கிஂக்டம் , ராகுல் பண்டிட் , அரவிந்த் மண் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , ஆரோக்கியம் அமைச்சகம் ,